Icon Advisers Inc Vertex Pharmaceuticals Inc Transaction History

Icon Advisers Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$255.65 - $303.1 $1.92 Million - $2.28 Million	-7,506 Closed	0 $0
Q2 2020 Aug 03, 2020	SELL	$225.48 - $295.8 $880,273 - $1.15 Million	-3,904 Reduced 34.22%	7,506 $2.18 Million
Q3 2019 Nov 01, 2019	SELL	$166.23 - $187.09 $731,412 - $823,196	-4,400 Reduced 27.83%	11,410 $1.93 Million
Q2 2019 Aug 02, 2019	SELL	$164.61 - $190.37 $1.7 Million - $1.96 Million	-10,320 Reduced 39.49%	15,810 $2.9 Million
Q3 2018 Nov 05, 2018	SELL	$167.73 - $192.74 $4.5 Million - $5.17 Million	-26,810 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$145.72 - $169.96 $3.83 Million - $4.46 Million	-26,253 Reduced 49.48%	26,810 $4.56 Million
Q4 2017 Feb 06, 2018	SELL	$137.28 - $155.55 $192,192 - $217,770	-1,400 Reduced 2.57%	53,063 $7.95 Million
Q3 2017 Nov 08, 2017	BUY	$148.13 - $162.24 $8.07 Million - $8.84 Million	54,463	54,463 $8.28 Million

1,708

220M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $113B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Icon Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Icon Advisers Inc with notifications on news.